Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CLEAR Registry Study: An Open, 5-year Registry Study to Track Clinical Application of DecisionDx-UM Multigene Assay Results and Associated Patient Outcomes.

NCT02376920 is registered in ClinicalTrials.gov with Castle Biosciences Incorporated as lead sponsor.

NCT NCT02376920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02376920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CLEAR Registry Study: An Open, 5-year Registry Study to Track Clinical Application of DecisionDx-UM Multigene Assay Results and Associated Patient Outcomes.
Lead sponsor
Castle Biosciences Incorporated
Phase
Observational
Overall status
Completed
Start date
March 31, 2010
Completion date
April 30, 2022
Enrollment
93 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

uveal melanoma